{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:21:47Z","timestamp":1788798107293,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Funds for Clinical Medical Research of Zhejiang Medical Association","award":["2021ZYC-A44"],"award-info":[{"award-number":["2021ZYC-A44"]}]},{"name":"Special Funds for Clinical Medical Research of Zhejiang Medical Association","award":["2021ZYC-A44"],"award-info":[{"award-number":["2021ZYC-A44"]}]},{"name":"Special Funds for Clinical Medical Research of Zhejiang Medical Association","award":["2021ZYC-A44"],"award-info":[{"award-number":["2021ZYC-A44"]}]},{"name":"Special Funds for Clinical Medical Research of Zhejiang Medical Association","award":["2021ZYC-A44"],"award-info":[{"award-number":["2021ZYC-A44"]}]},{"name":"Special Funds for Clinical Medical Research of Zhejiang Medical Association","award":["2021ZYC-A44"],"award-info":[{"award-number":["2021ZYC-A44"]}]},{"name":"Special Funds for Clinical Medical Research of Zhejiang Medical Association","award":["2021ZYC-A44"],"award-info":[{"award-number":["2021ZYC-A44"]}]},{"name":"Special Funds for Clinical Medical Research of Zhejiang Medical Association","award":["2021ZYC-A44"],"award-info":[{"award-number":["2021ZYC-A44"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04128-1","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:42:26Z","timestamp":1742377346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The efficacy of levodopa\/carbidopa\/entacapone on cognitive function in moderate to advanced Parkinson\u2019s disease and its relationship with peripheral inflammatory cytokines"],"prefix":"10.1186","volume":"25","author":[{"given":"Dongjuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"4128_CR1","doi-asserted-by":"publisher","unstructured":"Ronald BP, Daniela B, Matthew S, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30. https:\/\/doi.org\/10.1002\/mds.26424.","DOI":"10.1002\/mds.26424"},{"key":"4128_CR2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/s1474-4422(18)30355-7","volume":"17","author":"WA Rocca","year":"2018","unstructured":"Rocca WA. The burden of Parkinson\u2019s disease: a worldwide perspective. Lancet Neurol. 2018;17:928\u20139. https:\/\/doi.org\/10.1016\/s1474-4422(18)30355-7.","journal-title":"Lancet Neurol"},{"key":"4128_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/cia.s6456","volume":"5","author":"W Poewe","year":"2010","unstructured":"Poewe W, Antonini A, Zijlmans J, et al. Levodopa in the treatment of Parkinson\u2019s disease: an old drug still going strong. Clin Interv Aging. 2010;5:229\u201338. https:\/\/doi.org\/10.2147\/cia.s6456.","journal-title":"Clin Interv Aging"},{"key":"4128_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00228-009-0622-y","volume":"65","author":"M Kuoppam\u00e4ki","year":"2009","unstructured":"Kuoppam\u00e4ki M, Korpela K, Marttila R, et al. Comparison of Pharmacokinetic profile of Levodopa throughout the day between Levodopa\/carbidopa\/entacapone and Levodopa\/carbidopa when administered four or five times daily. Eur J Clin Pharmacol. 2009;65:443\u201355. https:\/\/doi.org\/10.1007\/s00228-009-0622-y.","journal-title":"Eur J Clin Pharmacol"},{"key":"4128_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, Das A, Ray SK, et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87:10\u201320. https:\/\/doi.org\/10.1016\/j.brainresbull.2011.10.004.","journal-title":"Brain Res Bull"},{"key":"4128_CR6","doi-asserted-by":"publisher","unstructured":"Pajares M, Rojo I, Manda A G, et al. Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells. 2020;9. https:\/\/doi.org\/10.3390\/cells9071687.","DOI":"10.3390\/cells9071687"},{"key":"4128_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4274\/balkanmedj.galenos.2022.2022-7-100","volume":"39","author":"E \u00c7\u0131nar","year":"2022","unstructured":"\u00c7\u0131nar E, Tel BC, \u015eahin G. Neuroinflammation in Parkinson\u2019s disease and its treatment opportunities. Balkan Med J. 2022;39:318\u201333. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2022.2022-7-100.","journal-title":"Balkan Med J"},{"key":"4128_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11481-012-9401-0","volume":"8","author":"D B\u00e9raud","year":"2013","unstructured":"B\u00e9raud D, Hathaway HA, Trecki J, et al. Microglial activation and antioxidant responses induced by the Parkinson\u2019s disease protein \u03b1-synuclein. J Neuroimmune Pharmacology: Official J Soc NeuroImmune Pharmacol. 2013;8:94\u2013117. https:\/\/doi.org\/10.1007\/s11481-012-9401-0.","journal-title":"J Neuroimmune Pharmacology: Official J Soc NeuroImmune Pharmacol"},{"key":"4128_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Translational Neurodegeneration. 2015;4:19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0.","journal-title":"Translational Neurodegeneration"},{"key":"4128_CR10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","volume":"31","author":"CH Williams-Gray","year":"2016","unstructured":"Williams-Gray CH, Wijeyekoon R, Yarnall AJ, et al. Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD). Mov Disorders: Official J Mov Disorder Soc. 2016;31:995\u20131003. https:\/\/doi.org\/10.1002\/mds.26563.","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"key":"4128_CR11","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"X-Y Qin","year":"2016","unstructured":"Qin X-Y, Zhang S-P, Cao C, et al. Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: A systematic review and Meta-analysis. JAMA Neurol. 2016;73:1316\u201324. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2742.","journal-title":"JAMA Neurol"},{"key":"4128_CR12","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.3233\/jpd-191729","volume":"9","author":"T Brudek","year":"2019","unstructured":"Brudek T. Inflammatory bowel diseases and Parkinson\u2019s disease. J Parkinsons Dis. 2019;9:S331\u201344. https:\/\/doi.org\/10.3233\/jpd-191729.","journal-title":"J Parkinsons Dis"},{"key":"4128_CR13","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00415-019-09321-0","volume":"267","author":"M Rolli-Derkinderen","year":"2020","unstructured":"Rolli-Derkinderen M, Leclair-Visonneau L, Bourreille A, et al. Is Parkinson\u2019s disease a chronic low-grade inflammatory bowel disease? J Neurol. 2020;267:2207\u201313. https:\/\/doi.org\/10.1007\/s00415-019-09321-0.","journal-title":"J Neurol"},{"key":"4128_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/1750-3841.13620","volume":"82","author":"SK Ha","year":"2017","unstructured":"Ha SK, Lee JA, Cho EJ, et al. Effects of catechol O-Methyl transferase Inhibition on Anti-Inflammatory activity of Luteolin metabolites. J Food Sci. 2017;82:545\u201352. https:\/\/doi.org\/10.1111\/1750-3841.13620.","journal-title":"J Food Sci"},{"key":"4128_CR15","doi-asserted-by":"publisher","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427-42. https:\/\/doi.org\/10.1212\/wnl.17.5.427","DOI":"10.1212\/wnl.17.5.427"},{"key":"4128_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/mds.22343","volume":"24","author":"R Hauser","year":"2009","unstructured":"Hauser R, Panisset M, Abbruzzese G, et al. Double-blind trial of Levodopa\/carbidopa\/entacapone versus Levodopa\/carbidopa in early Parkinson\u2019s disease. Mov Disorders: Official J Mov Disorder Soc. 2009;24:541\u201350. https:\/\/doi.org\/10.1002\/mds.22343.","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"key":"4128_CR17","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"C Tomlinson","year":"2010","unstructured":"Tomlinson C, Stowe R, Patel S, et al. Systematic review of Levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disorders: Official J Mov Disorder Soc. 2010;25:2649\u201353. https:\/\/doi.org\/10.1002\/mds.23429.","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"key":"4128_CR18","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, et al. Movement disorder Society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129\u201370. https:\/\/doi.org\/10.1002\/mds.22340.","journal-title":"Mov Disord"},{"key":"4128_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/bf02260863","volume":"4","author":"V Peto","year":"1995","unstructured":"Peto V, Jenkinson C, Fitzpatrick R, et al. The development and validation of a short measure of functioning and well being for individuals with Parkinson\u2019s disease. Qual Life Res. 1995;4:241\u20138. https:\/\/doi.org\/10.1007\/bf02260863.","journal-title":"Qual Life Res"},{"issue":"3","key":"4128_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental State. A practical method for grading the cognitive State.of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"4128_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-244x-12-156","volume":"12","author":"Y Jing","year":"2012","unstructured":"Jing Y, Juan L, Xin H. The Beijing version of the Montreal cognitive assessment as a brief screening tool for mild cognitive impairment: a community-based study. BMC Psychiatry. 2012;12(1):156. https:\/\/doi.org\/10.1186\/1471-244x-12-156.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"4128_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety States by rating. Br J Med Psychol. 1959;32(1):50\u20135. https:\/\/doi.org\/10.1111\/j.2044-8341.1959.tb00467.x.","journal-title":"Br J Med Psychol"},{"issue":"1","key":"4128_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56\u201362. https:\/\/doi.org\/10.1136\/jnnp.23.1.56.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4128_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27:27\u201342. https:\/\/doi.org\/10.1111\/ene.14108.","journal-title":"Eur J Neurol"},{"key":"4128_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","volume":"103","author":"S Reich","year":"2019","unstructured":"Reich S, Savitt J. Parkinson\u2019s disease. Med Clin N Am. 2019;103:337\u201350. https:\/\/doi.org\/10.1016\/j.mcna.2018.10.014.","journal-title":"Med Clin N Am"},{"key":"4128_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5694\/mja2.50224","volume":"211","author":"M Hayes","year":"2019","unstructured":"Hayes M, Fung V, Kimber T, et al. Updates and advances in the treatment of Parkinson disease. Med J Australia. 2019;211:277\u201383. https:\/\/doi.org\/10.5694\/mja2.50224.","journal-title":"Med J Australia"},{"key":"4128_CR27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: A review. JAMA. 2020;323:548\u201360. https:\/\/doi.org\/10.1001\/jama.2019.22360.","journal-title":"JAMA"},{"key":"4128_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2147\/tcrm.S163190","volume":"14","author":"ZM Yi","year":"2018","unstructured":"Yi ZM, Qiu TT, Zhang Y, et al. Levodopa\/carbidopa\/entacapone versus levodopa\/dopa-decarboxyiase inhibitor for the treatment of Parkinson\u2019s disease: systematic review, meta-analysis, and economic evaluation. Ther Clin Risk Manag. 2018;14:709\u201319. https:\/\/doi.org\/10.2147\/tcrm.S163190.","journal-title":"Ther Clin Risk Manag"},{"key":"4128_CR29","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s10072-020-04303-x","volume":"41","author":"X Liao","year":"2020","unstructured":"Liao X, Wu N, Liu D, et al. Levodopa\/carbidopa\/entacapone for the treatment of early Parkinson\u2019s disease: a meta-analysis. Neurol Sci. 2020;41:2045\u201354. https:\/\/doi.org\/10.1007\/s10072-020-04303-x.","journal-title":"Neurol Sci"},{"key":"4128_CR30","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4103\/neuroindia.NI_597_16","volume":"65","author":"J Park","year":"2017","unstructured":"Park J, Kim Y, Youn J, et al. Levodopa dose maintenance or reduction in patients with Parkinson\u2019s disease transitioning to Levodopa\/carbidopa\/entacapone. Neurol India. 2017;65:746\u201351. https:\/\/doi.org\/10.4103\/neuroindia.NI_597_16.","journal-title":"Neurol India"},{"key":"4128_CR31","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s10072-020-04303-x","volume":"41","author":"X Liao","year":"2020","unstructured":"Liao X, Wu N, Liu D, et al. Levodopa\/carbidopa\/entacapone for the treatment of early Parkinson\u2019s disease: a meta-analysis. Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol. 2020;41:2045\u201354. https:\/\/doi.org\/10.1007\/s10072-020-04303-x.","journal-title":"Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol"},{"key":"4128_CR32","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1212\/wnl.50.6_suppl_6.s27","volume":"50","author":"P Mart\u00ednez-Mart\u00edn","year":"1998","unstructured":"Mart\u00ednez-Mart\u00edn P, O\u2019Brien CF. Extending Levodopa action: COMT Inhibition. Neurology. 1998;50:S27\u201332. https:\/\/doi.org\/10.1212\/wnl.50.6_suppl_6.s27. discussion S44-28.","journal-title":"Neurology"},{"key":"4128_CR33","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1177\/0269881112454228","volume":"26","author":"LM Laatikainen","year":"2012","unstructured":"Laatikainen LM, Sharp T, Bannerman DM, et al. Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase Inhibition. J Psychopharmacol (Oxford England). 2012;26:1561\u20138. https:\/\/doi.org\/10.1177\/0269881112454228.","journal-title":"J Psychopharmacol (Oxford England)"},{"key":"4128_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.parkreldis.2005.01.007","volume":"11","author":"P Valkovic","year":"2005","unstructured":"Valkovic P, Benetin J, Blaz\u00edcek P, et al. Reduced plasma homocysteine levels in Levodopa\/entacapone treated Parkinson patients. Parkinsonism Relat Disord. 2005;11:253\u20136. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.01.007.","journal-title":"Parkinsonism Relat Disord"},{"key":"4128_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11361-y","author":"MT Peri\u00f1\u00e1n","year":"2022","unstructured":"Peri\u00f1\u00e1n MT, Mac\u00edas-Garc\u00eda D, Jes\u00fas S, et al. Homocysteine levels, genetic background, and cognitive impairment in Parkinson\u2019s disease. J Neurol. 2022. https:\/\/doi.org\/10.1007\/s00415-022-11361-y.","journal-title":"J Neurol"},{"key":"4128_CR36","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/mds.23738","volume":"26","author":"HA Hanagasi","year":"2011","unstructured":"Hanagasi HA, Gurvit H, Unsalan P, et al. The effects of Rasagiline on cognitive deficits in Parkinson\u2019s disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study. Mov Disord. 2011;26:1851\u20138. https:\/\/doi.org\/10.1002\/mds.23738.","journal-title":"Mov Disord"},{"key":"4128_CR37","doi-asserted-by":"publisher","first-page":"a009381","DOI":"10.1101\/cshperspect.a009381","volume":"2","author":"RL Mosley","year":"2012","unstructured":"Mosley RL, Hutter-Saunders JA, Stone DK, et al. Inflammation and adaptive immunity in Parkinson\u2019s disease. Cold Spring Harbor Perspect Med. 2012;2:a009381. https:\/\/doi.org\/10.1101\/cshperspect.a009381.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"4128_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","volume":"327","author":"MN Karpenko","year":"2018","unstructured":"Karpenko MN, Vasilishina AA, Gromova EA, et al. Interleukin-1\u03b2, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease. Cell Immunol. 2018;327:77\u201382. https:\/\/doi.org\/10.1016\/j.cellimm.2018.02.011.","journal-title":"Cell Immunol"},{"key":"4128_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cell.2020.02.013","volume":"180","author":"E Willis","year":"2020","unstructured":"Willis E, MacDonald K, Nguyen Q, et al. Repopulating microglia promote brain repair in an IL-6-Dependent manner. Cell. 2020;180:833\u2013e846816. https:\/\/doi.org\/10.1016\/j.cell.2020.02.013.","journal-title":"Cell"},{"key":"4128_CR40","doi-asserted-by":"publisher","unstructured":"Chan L, Chung C-C, Chen J-H, et al., et al. Cytokine Profile in Plasma Extracellular Vesicles of Parkinson\u2019s Disease and the Association with Cognitive Function. Cells. 2021;10. https:\/\/doi.org\/10.3390\/cells10030604.","DOI":"10.3390\/cells10030604"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04128-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04128-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04128-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:42:31Z","timestamp":1742377351000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04128-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4128"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04128-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the Dongyang People\u2019s Hospital, Affiliated to Wenzhou Medical University (Ethic ID: 2021-YX-037). All participants signed written informed consents. All methods were performed in accordance with the national guidelines and regulations and the ethical standards of the Declaration of Helsinki 1964.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}